The Director General, Nigeria Institute of Medical Research Prof. Babatunde Salako, on Monday, said the institute has discovered a new malaria vector called anopheles stephensi in northern Nigeria.
Salako who spoke with newsmen in Lagos during a birthday ceremony organised by his members of staff said that it was the most recent research discovery.
He said that it was a rugged vector, very difficult to eradicate, adding that it had not been found anywhere near West Africa.
He said that this was a discovery by NIMR researchers and that had implications for malaria control in Nigeria.
Salako said that NIMR currently was looking at vaccines.
Read Also: Group decries non-availability of Liver transplant Centres in Nigeria
“We have done a lot of studies on vaccines and we are looking at vaccine development.
“We are working with five groups in a consortium to develop world local vaccines in Nigeria which was different from production,” he said.
Salako said that the idea was to ensure that Nigerian researchers were able to take it from the beginning to the end in the development of vaccines.
He said that “if tomorrow, we had a new epidemic or disease, known or unknown, it would be possible for Nigeria to develop its own vaccine”.
He said that NIMR was also looking at the effectiveness, side effects, and responsiveness of the human body to COVID-19 vaccines.
He said that the institute was looking at three COVID vaccines, disclosing that 2,000 people in Nigeria would be tested to know whether the vaccines evoked response among Nigerians.
Discover more from LN247
Subscribe to get the latest posts sent to your email.
